A Study of PF-08032562 in People With Solid Tumor Cancer

Full Title

A Phase 1 Dose Escalation And Expansion Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Anti-Tumor Activity of PF-08032562 in Participants with Advanced or Metastatic Solid Tumors

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Komal Jhaveri’s office at 646-888-5157.